PCCA International Seminar logo

Your Compounding Connections Start Here
2019 International Seminar

The professional development and networking event of the year, International Seminar is where compounders connect with:

  • What’s Now - Expert insights and knowledge from 30+ engaging speakers covering clinical, business and technical topics
  • What’s New - Innovative solutions for tackling tough patient problems
  • What’s Next - Emerging trends and groundbreaking advancements in the industry

Connect with compounding pharmacists, technicians and marketers from across the United States, Canada, Australia and beyond, and be among the first to see PCCA’s new bases, products and technology.

An Experience That Will Inspire You
See all of our keynotes and speakers here

Jill Carnahan

Jill Carnahan, MD, ABIHM, ABoIM, IFMCP, moved to Boulder, Colorado, in 2010 joining medical partner, Dr. Robert Rountree. Dr. Carnahan recently opened her own practice, Flatiron Functional Medicine in Louisville, Colorado, to offer more services. She was board certified in both family medicine in 2006-2016 and in integrative holistic medicine in 2005. She founded the Methodist Center for Integrative Medicine in 2009 and worked there as integrative medical director until October 2010. She completed her residency at the University of Illinois Program in Family Medicine at Methodist Medical Center and received her medical degree from Loyola University Stritch School of Medicine in Chicago. She received her Bachelor of Science in bio-engineering at the University of Illinois in Champaign-Urbana.

Saturday, Oct. 12, 9:00 am: Metabolic Endotoxemia and Chronic Diseases (CE)

Scott Gottlieb

Scott Gottlieb, MD, as the 23rd commissioner of the U.S. Food and Drug Administration, Scott Gottlieb, MD, focused on advancing public health through developing and implementing innovative approaches to improving medical outcomes, reshaping healthcare delivery, and expanding consumer choice and safety. Dr. Gottlieb is an aggressive advocate for advancing the health of patients, promoting healthcare access and driving innovation. The agency’s historic and prolific advances in new policy distinguished his tenure as the FDA’s commissioner, in addition to a record-setting number of approvals of novel drugs, medical devices and generic medicines.

Under his leadership, the FDA advanced new frameworks for the modern and safe and effective oversight of gene therapies, cell-based regenerative medicines, targeted drugs and digital health devices. The agency implemented new reforms to standardize drug reviews and make historic improvements of post-market data collection and the use of real-world evidence. They promoted policies to reduce death and disease from tobacco, improve food innovation and safety, and aggressively confront addiction crises. 

Previously, Dr. Gottlieb served as the FDA’s deputy commissioner for Medical and Scientific Affairs and, before that, as a senior adviser to the administrator of the Centers for Medicare and Medicaid Services. A healthcare futurist, he has worked as a venture capitalist and founder and board member to companies that have developed new medicines and advanced the delivery of healthcare.

Dr. Gottlieb is widely published in leading medical journals and periodicals, including The Wall StreetJournal, The New York Times and The Washington Post, and appears regularly as a guest commentator on CNBC. Fortune magazine recognized him as one of the “World’s 50 Greatest Leaders” in 2018 and 2019. Modern Healthcare named Dr. Gottlieb as one of the “Most Influential Physician Executive and Leaders” in its annual survey of 50 physician executives, and Time magazine named him one of its “50 People Transforming Healthcare in 2018.” Dr. Gottlieb was a practicing hospitalist and a clinical assistant professor at the New York University School of Medicine. He is a member of the National Academy of Medicine and a Resident Fellow at the American Enterprise Institute in Washington, DC.

Thursday, Oct 10, 1:30 pm: Keynote Address (CE)

Mark Rosenberg

Mark A. Rosenberg, MD, is president and medical director, Advanced Medical Therapeutics and Integrative Cancer Therapeutics; program director, Integrative Cancer Fellowship; chief medical officer, Laboratory for Advanced Medicine; co-founder, Channel Therapeutics, LLC; and co-founder, HighPoint Therapeutics, LLC. Dr. Rosenberg received his doctorate from Georgetown University School of Medicine in 1988 and has been involved with drug research since 1991. An astute clinician and innovator, he is constantly developing new ideas, techniques and drugs to combat cancer, obesity and age-related diseases. With numerous certifications in several different fields of medicine, psychology and fitness, he has a wide breadth of experience in both the public and private sector with particular expertise in the mechanism of cancer treatment failure. Dr. Rosenberg’s work has been published in many trade and academic journals, and he currently is researching new compounds to treat cancer and obesity, including receiving approval status for an investigational new drug that works with chemotherapy and a patent pending for an oral appetite suppressant.

Thursday, Oct. 10, 8:30 am: Systemic Cancer Treatment: Time for a Paradigm Change (CE)

Thursday, Oct. 10, 11:00 am: WORKSHOP CLINICAL TRACK 1: Integrative Treatments for Advanced-Stage Cancer (CE)

Pamela W. Smith

Pamela W. Smith, MD, MPH, MS, spent her first 20 years of practice as an emergency room physician with the Detroit Medical Center and then the next 20 years as an anti-aging/functional medicine specialist. Dr. Smith is a diplomat of the Board of the American Academy of Anti-Aging Physicians and is an internationally known speaker and author on the subject of metabolic, anti-aging and functional medicine. She also holds a master’s degree in Public Health along with a master’s degree in metabolic and nutritional medicine. She has been featured on CNN, PBS and many other television networks; has been interviewed in numerous consumer magazines; and has hosted two of her own radio shows. She is a regular contributor for Fox News Radio. Dr. Smith is currently the director of the Center for Personalized Medicine and the founder of The Fellowship in Anti-Aging, Regenerative, and Functional Medicine. She is also the co-director of the Master’s Program in Metabolic and Nutritional Medicine at the Morsani College of Medicine, University of South Florida. Dr. Smith is the author of the best-selling books: HRT: The Answers; Vitamins Hype or Hope; Demystifying Weight Loss; What You Must Know About Vitamins, Minerals, Herbs & More; What You Must Know about Women’s Hormones; Why You Can’t Lose Weight; What You Must Know About Memory Loss and How You Can Stop It; What You Must Know About Thyroid Disorders; and What You Must Know About Allergy Relief, of which she is a co-author. Her latest book, What You Must Know About Autoimmune Diseases, was published in 2018.

Thursday, Oct. 10, 2:30 pm: WORKSHOP CLINICAL TRACK 1: Heart Health: The Importance of Hormonal Balance for Men and Women (CE)

Friday, Oct. 11, 1:15 pm: Most Common Patient Complaint: Fatigue (CE)

Friday, Oct. 11, 4:00 pm: How to Positively Affect Your Bottom Line (Non-CE)

Book Your Hotel

Enjoy all that downtown Houston has to offer from our host hotel, Hilton Americas-Houston. Dining and entertainment venues are just steps away. To get the best rate for your stay, make your reservation before September 18, 2019.

Book Now

Book Your Hotel

Enjoy all that downtown Houston has to offer from our host hotel, Hilton Americas-Houston. Dining and entertainment venues are just steps away. To get the best rate for your stay, make your reservation before September 18, 2019.

Book Now
International Seminar 2019 - Ready To Learn?

The 2019 International Seminar is sponsored by an educational grant from PCCA. The maximum hours of CE credit available at International Seminar totals 13.25. Note that in order to obtain 13.25 hours, CE workshop sessions and the CE session during Personal Growth and Development must be attended. This will include 1 hour of live law CE as required by many State Boards and PTCB.